ArticleFrontiers in oncology2021

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer.

Jiayu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.